In conclusion, ROS induced by ALDH2 deficiency can be tolerated in cancer cells, resulting in tumor progression; whereas ROS is intolerant in normal cells, resulting in the elimination of BASCs (Fig. 1P; Fig. S8). The gene discussed is ALDH2; the disease is cancer.